UnitedHealth director awarded 210 deferred stock units

UnitedHealth Group director Scott Gottlieb reported a routine equity grant of 210 deferred stock units of common stock.

Rhea-AI Filing Summary

UnitedHealth Group director Scott Gottlieb reported a routine equity grant of 210 deferred stock units of common stock. The units were granted as regular quarterly compensation for his service on the board and carry no cash exercise price. After this award, he directly holds 659 deferred stock units. According to the disclosure, these units vest immediately but must be retained until he completes his service on the board, so they function as long-term, stock-based director compensation rather than a short-term trading position.

Insider Trade Summary

Grant/Award: 210 shares

Grant/Award 1 txn

Insider Gottlieb Scott

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	210	$0.00	$0.00

Holdings After Transaction: Common Stock — 659 shares (Direct)

Footnotes (1)

1. F1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Key Figures

Deferred stock units granted: 210 units Price per deferred stock unit: $0.00 per share Total units after transaction: 659 units +2 more

5 metrics

Deferred stock units granted 210 units Quarterly director compensation grant on July 1, 2026

Price per deferred stock unit $0.00 per share Non-cash equity award for director service

Total units after transaction 659 units Scott Gottlieb’s direct holdings following the grant

Transaction code A Grant, award, or other acquisition of common stock units

Transaction direction acquire Non-derivative equity award reported in Form 4

Key Terms

deferred stock units, regular quarterly compensation, immediately vested, Form 4

4 terms

deferred stock units financial

"Represents deferred stock units that are granted as regular quarterly compensation for service as a director"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

regular quarterly compensation financial

"deferred stock units that are granted as regular quarterly compensation for service as a director"

immediately vested financial

"Deferred stock units are immediately vested, but must be retained by the director"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Scott Gottlieb report in his latest Form 4 for UNITEDHEALTH GROUP INC (UNH)?

Scott Gottlieb reported receiving 210 deferred stock units of UnitedHealth Group common stock as regular quarterly director compensation. These equity units vest immediately but must be held until he completes his service on the board, aligning his compensation with long-term shareholder interests.

How many UnitedHealth Group (UNH) deferred stock units does Scott Gottlieb hold after this Form 4?

After this award, Scott Gottlieb holds 659 deferred stock units of UnitedHealth Group common stock. The filing states these units are immediately vested but must be retained until his board service ends, reinforcing ongoing equity-based alignment with the company’s performance over time.

What type of insider transaction did UNH director Scott Gottlieb report in this Form 4?

The Form 4 shows a grant or award acquisition coded as an “A” transaction, representing 210 deferred stock units. This is non-cash director compensation rather than an open-market purchase or sale, and is described as regular quarterly compensation for board service at UnitedHealth Group.

Are Scott Gottlieb’s UnitedHealth (UNH) deferred stock units immediately vested and tradable?

The deferred stock units are immediately vested but not freely tradable. The disclosure explains they must be retained by Scott Gottlieb until he completes his service on UnitedHealth Group’s board, so they function as long-term equity that cannot be sold during his directorship.

Is Scott Gottlieb’s Form 4 transaction in UnitedHealth Group (UNH) an open-market buy or sell?

The transaction is not an open-market buy or sell. It is a grant of 210 deferred stock units as regular quarterly director compensation, reported under transaction code “A.” The units are awarded at a price of $0.00 per share and must be held until his board service ends.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:44 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gottlieb Scott

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		210(1)	A	$0	659	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Scott M. Gottlieb M.D.	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)